Lasa Supergenerics Limited has announced the closure of its trading window for designated employees and their immediate relatives. This closure will be effective from January 01, 2026, and will remain in effect until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended December 31, 2025. The decision is in accordance with the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, as per the Prohibition of Insider Trading Regulations, 2015, as amended. The company has informed BSE Limited and the National Stock Exchange of India Limited about this closure. The Unaudited Financial Results for the third quarter of the fiscal year 2025-2026 are expected to be declared soon, following which the trading window will be reopened.
